<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01899339</url>
  </required_header>
  <id_info>
    <org_study_id>2013-069</org_study_id>
    <secondary_id>Ekos</secondary_id>
    <nct_id>NCT01899339</nct_id>
  </id_info>
  <brief_title>Long Term Study Looking at the Effects of Treating Submassive Pulmonary Embolism With Ultra-sound Accelerated Thrombolysis</brief_title>
  <acronym>SPEAR</acronym>
  <official_title>Submassive Pulmonary Embolism Treatment With Ultrasound-Accelerated Thrombolysis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Spectrum Health Hospitals</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>EKOS Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Advanced Radiology Services</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Spectrum Health Hospitals</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with Submassive Pulmonary Embolism treated with ultra-sound therapy will have an
      improved right ventricular function 72 hours post treatment.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>May 2013</start_date>
  <completion_date type="Anticipated">May 2014</completion_date>
  <primary_completion_date type="Anticipated">May 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Right Ventricular:Left Ventricular ratio</measure>
    <time_frame>baseline to 72 hours post</time_frame>
    <description>Treatment will show improved Right Ventricular:Left Ventricular ratio at 72 hours post.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>recurrent pulmonary embolism</measure>
    <time_frame>30 days post procedure</time_frame>
    <description>Will assess whether a recurrent Pulmonary Embolism has happened at 30 day post procedure or earlier</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Treatment of Submassive Pulmonary Embolism</condition>
  <arm_group>
    <arm_group_label>pulmonary embolism</arm_group_label>
    <description>patients with submassive pulmonary embolism</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Ultra sound energy along with tPA to treat submassive pulmonary embolism</intervention_name>
    <arm_group_label>pulmonary embolism</arm_group_label>
    <other_name>Ekosonic Endovascular Device</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patient presenting to the Emergency Department with submassive pulmonary hypertension
        over the age of 18.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with acute (&lt; or = 14 days)symptomatic pulmonary embolism by CT Angiogram of
             the thorax with embolus involving at least one main or lower lobe pulmonary artery and
             RV:LV ratio &gt; 0.9

        Exclusion Criteria:

          -  age &gt; 80

          -  Recent thrombolytic therapy (with in 4 days)

          -  Active bleeding or know bleeding diathesis

          -  Known coagulopathy (including treatment with vitamin K antagonists) INR &gt; 3 and/or PTT
             &gt; 50

          -  Thrombocytopenia (PLT cound &lt; 100,000)

          -  History of any intracranial or intraspinal surgery, trauma or bleed

          -  Intracranial neoplasms, AVM, or aneurysm

          -  Recent (&lt; 1 month) GI bleed

          -  Recent (&lt; 3 months) internal eye surgery or hemorrhagic retinopathy

          -  Recent (&lt; 7 days) major surgery, trauma, or obstetrical delivery

          -  Renal insufficiency with eGFR &lt; 45 ml/min

          -  Known allergy, hypersensitivity, or thrombocytopenia from heparin or tPA

          -  Hemodynamic instability defined as need for cardiopulmonay resuscitation, Systolic BP
             &gt; 90 mm Hg for &gt; 15 min or need for pressor agents to maintain BP &gt; 90.

          -  Severe Hypertension (sustained systolic &gt; 180 mm Hg or diastolic &gt; 90 mm Hg.

          -  Pregnant patients

          -  known right to left shunt

          -  Large (&gt;10 mm)intracardiac thrombus

          -  Use of thrombolytics or glycoprotein IIb/IIIa antangonists within 3 days of inclusion.

          -  Life expectancy &lt; 30 days
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Spectrum Health Hospitals</name>
      <address>
        <city>Grand Rapids</city>
        <state>Michigan</state>
        <zip>49503</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julie A Bishop, BSN</last_name>
      <phone>616-391-2724</phone>
      <email>julie.bishop@spectrumhealth.org</email>
    </contact>
    <investigator>
      <last_name>Michael Knox, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 10, 2013</study_first_submitted>
  <study_first_submitted_qc>July 12, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 15, 2013</study_first_posted>
  <last_update_submitted>July 12, 2013</last_update_submitted>
  <last_update_submitted_qc>July 12, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 15, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Spectrum Health Hospitals</investigator_affiliation>
    <investigator_full_name>Michael F Knox, MD</investigator_full_name>
    <investigator_title>Medical Doctor</investigator_title>
  </responsible_party>
  <keyword>submassive pulmonary embolism</keyword>
  <keyword>Ultrasonic energy</keyword>
  <keyword>Ekosonic Endovascular Device</keyword>
  <keyword>RV:LV function after Pulmonary Embolism</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Embolism</mesh_term>
    <mesh_term>Pulmonary Embolism</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

